Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

4 Résultats
Structure : Identifiant HAL de la structure : 438873

Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial

Y. Touchefeu , R. Guimbaud , C. Louvet , L. Dahan , E. Samalin et al.
Gastric Cancer, In press, pp.1-10. ⟨10.1007/s10120-018-0885-z⟩
Article dans une revue hal-01986753v1

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stefano Kim , Eric François , Thierry André , Emmanuelle Samalin , Marine Jary et al.
Lancet Oncology, 2018, 19 (8), pp.1094 - 1106. ⟨10.1016/S1470-2045(18)30321-8⟩
Article dans une revue hal-01863908v1

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Franck Bonnetain , Bert Bonsing , Thierry Conroy , Adelaide Dousseau , Bengt Glimelius et al.
European Journal of Cancer, 2014, 50 (17), pp.2983 - 2993. ⟨10.1016/j.ejca.2014.07.011⟩
Article dans une revue hal-01802621v1
Image document

Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty

Dewi Vernerey , Amelie Anota , Pierre Vandel , Sophie Bailly , Michele Dion et al.
BMC Geriatrics, 2016, 16 (1), pp.187. ⟨10.1186/s12877-016-0360-9⟩
Article dans une revue hal-01444161v1